rapid
acut
onset
bronchiol
obliteran
syndrom
lung
transplant
recipi
respiratori
syncyti
viru
infect
transpl
infect
di
right
reserv
abstract
bronchiol
obliteran
syndrom
bo
either
acut
chronic
onset
abrupt
insidi
cours
diagnosi
typic
achiev
physiolog
criteria
develop
sustain
declin
expiratori
flow
rate
least
week
review
rapid
develop
acut
bo
bronchiectasi
respiratori
syncyti
viru
infect
lung
transplant
recipi
well
normal
pulmonari
function
year
lung
transplant
diagnosi
bronchiol
obliteran
syndrom
bo
current
achiev
use
spirometr
criteria
sustain
declin
expiratori
flow
rate
least
week
exclus
altern
caus
includ
acut
allograft
reject
anastomot
complic
infect
recurrentprogress
nativ
lung
diseas
diagnosi
bo
actual
requir
histolog
confirm
consid
surrog
physiolog
marker
presenc
oblit
bronchiol
ob
etiolog
bo
complet
understood
sever
associ
risk
factor
includ
alloimmunedepend
risk
acut
allograft
reject
lymphocyt
bronchitisbronchiol
organ
pneumonia
human
leukocyt
antigen
hla
mismatch
nonalloimmunedepend
risk
primari
graft
dysfunct
gastroesophag
reflux
numer
infecti
agent
bacteri
fungal
viral
time
develop
bo
highli
variabl
either
insidi
cours
gradual
declin
month
year
abrupt
cours
sever
declin
week
moreov
acut
chronic
onset
bo
also
occur
patient
acut
onset
bo
typic
irrevers
steep
declin
pulmonari
function
like
multipl
episod
acut
allograft
reject
first
month
surgeri
main
caus
death
ob
patient
chronic
onset
bo
indol
cours
acut
allograft
reject
marker
inflamm
infect
import
ob
play
smaller
role
caus
death
review
case
involv
patient
cystic
fibrosi
cf
complet
unev
cours
year
bilater
sequenti
lung
transplant
acut
respiratori
syncyti
viru
rsv
infect
trigger
sudden
onset
acut
allograft
reject
subsequ
led
rapid
develop
acut
onset
bo
bronchiectasi
woman
cf
homozygot
underw
bilater
sequenti
lung
transplant
year
earlier
develop
new
cough
rhinorrhea
day
cough
worsen
abruptli
develop
fatigu
dyspnea
rest
exert
previou
episod
acut
reject
known
viral
respiratori
tract
ill
sinc
transplant
spirometri
demonstr
forc
vital
capac
fvc
l
predict
forc
expiratori
volum
sec
fev
l
predict
recent
highresolut
comput
tomographi
ct
chest
demonstr
chronic
chang
clear
lung
field
fig
surgic
histori
nissen
fundopl
symptomat
gastroesophag
reflux
perform
discharg
lung
transplant
complet
resolut
symptom
histori
hla
mismatch
time
transplant
current
immunosuppress
therapi
tacrolimu
mg
twice
daili
mycophenol
mg
twice
daili
prednison
mg
daili
medic
includ
trimethoprimsulfamethoxazol
prophylaxi
pancreat
enzym
supplement
tacrolimu
level
accept
ngml
rang
unabl
perform
spirometri
current
acut
present
nasal
swab
sampl
identifi
rsv
realtim
polymeras
chain
reaction
bronchoscopi
perform
reveal
well
heal
anastomos
transbronchi
biopsi
show
giant
cell
fig
consist
rsv
well
sign
acut
allograft
reject
classifi
treat
inhal
ribavirin
highdos
daili
intraven
methylprednisolon
g
daili
day
tissu
bronchoalveolar
lavag
fluid
cultur
found
infecti
agent
upper
gastrointestin
studi
along
ph
probe
imped
reveal
evid
gastroesophag
reflux
aspir
blood
neg
cytomegaloviru
epsteinbarr
viru
spirometri
perform
day
present
reveal
sever
airway
obstruct
fvc
l
predict
fev
l
predict
one
week
initi
present
routin
ct
scan
chest
perform
vagu
chest
pain
show
ground
glass
opac
new
develop
bronchiectasi
fig
repeat
transbronchi
biopsi
week
initi
present
demonstr
complet
resolut
acut
reject
histolog
find
howev
pulmonari
function
improv
eventu
met
diagnost
criteria
bo
sinc
list
retransplant
understand
pathogenesi
rsv
bo
lung
transplant
remain
limit
howev
anoth
studi
investig
report
respiratori
viral
infect
associ
subsequ
graft
dysfunct
smaller
cohort
patient
follow
singl
winter
season
total
patient
symptomat
respiratori
viral
episod
document
infect
includ
rsv
n
influenza
n
parainfluenza
n
recent
hopkin
colleagu
report
cohort
patient
respiratori
viral
infect
signific
percentag
patient
metapneumoviru
rsv
develop
graft
dysfunct
averag
declin
fev
respect
subsequ
bo
onset
progress
occur
patient
human
metapneumoviru
compar
total
patient
rsv
month
patient
bo
reportedli
graft
dysfunct
time
diagnosi
rsv
infect
patient
rsv
initi
recov
baselin
respiratori
function
therapi
subsequ
develop
bo
mean
time
diagnosi
week
case
impress
time
acut
onset
bo
relat
rsv
infect
especi
base
complet
unev
cours
past
year
transplant
think
aggress
bo
support
rapid
chang
ct
imag
fig
b
myriad
abnorm
seen
ct
imag
chest
bo
includ
bronchiectasi
hyperluc
airtrap
mosaic
pattern
attenu
thicken
septal
line
treeinbud
ct
imag
often
use
complement
pulmonari
function
test
bronchoscopi
help
differenti
caus
dyspnea
declin
pulmonari
function
lung
transplant
recipi
report
jackson
et
al
bo
singl
process
acut
bo
defin
sharp
steep
irrevers
declin
fev
trigger
acut
event
associ
episod
acut
allograft
reject
first
month
poor
prognosi
chronic
form
disord
smooth
linear
declin
pulmonari
function
less
like
associ
acut
event
better
prognosi
case
illustr
differ
phenotyp
bo
exist
fact
acut
chronic
phenotyp
occur
time
lung
transplant
aggress
disord
even
impress
patient
present
herein
compar
case
report
prospect
studi
hopkin
et
al
addit
research
need
identifi
pathogenesi
rsv
infect
relat
develop
bo
lung
transplant
recipi
help
identifi
therapeut
target
optim
outcom
lung
transplant
